Pharmaceutical composition comprising n-3-chloro-4-(3-fluorobenzyloxy)phenyl-6-5({2-(methylsulfonyl)ethylamino}methyl)-2-furylquinazolin-4-amine or a pharmaceutically acceptable salt, solvate or solvated salt thereof

摘要

The present invention relates to a pharmaceutical composition comprising N-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-6-[5({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]quinazolin-4-amine or a pharmaceutically acceptable salt, solvate or solvated salt thereof, and a process for preparing the pharmaceutical composition.